Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (347437)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The grant aims to drive the development of groundbreaking tools and technologies within the realms of kidney, urologic, and hematologic diseases. It targets both standard research areas and those pertinent to AIDS, offering detailed deadlines for application submissions in both categories. The goal is to support innovations that can significantly advance the understanding, diagnosis, and treatment of these diseases.

    Eligibility

    Organization's Location
    voluptate cupidatat
    Program Location
    id
    Organization Type

    Submission

    Visit Apply for more information.